Crossmark

The efficacy of a coordinated pharmacological blockade in glioblastoma stem cells with nine repurposed drugs using the CUSP9 strategy

Crossref DOI link: https://doi.org/10.1007/s00432-019-02920-4

Published Online: 2019-04-26

Published Print: 2019-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Skaga, Erlend http://orcid.org/0000-0003-3942-3492
Skaga, Ida Ø.

Grieg, Zanina

Sandberg, Cecilie J.

Langmoen, Iver A.

Vik-Mo, Einar O.
Funding

Funding for this research was provided by:

Kreftforeningen (144402)
License Information

Text and Data Mining valid from 2019-04-26
More Information

Article History

Received: 25 December 2018

Accepted: 15 April 2019

First Online: 26 April 2019

Compliance with ethical standards

:

: The authors declare that they have no conflicts of interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.

: Informed consent was obtained from all individual participants included in the study.